Humana Inc. (NYSE:HUM) has a beta value of 0.88 and has seen 971,618 shares traded in the last trading session. The company, currently valued at $59.73 Billion, closed the last trade at $463 per share which meant it gained $12.4 on the day or 2.75% during that session. The HUM stock price is -2.53% off its 52-week high price of $474.7 and 31.3% above the 52-week low of $318.06. If we look at the company’s 10-day average daily trading volume, we find that it stood at 791.52 Million shares traded. The 3-month trading volume is 1.11 Million shares.
The consensus among analysts is that Humana Inc. (HUM) is an Overweight stock at the moment, with a recommendation rating of 2. None of the analysts rate the stock as a Sell, while none rate it as Overweight. 7 out of 23 have rated it as a Hold, with 16 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is $6.74.
Humana Inc. (NYSE:HUM) trade information
Sporting 2.75% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on Tuesday, May 04 when the HUM stock price touched $463.84 or saw a rise of 0.18%. Year-to-date, Humana Inc. shares have moved 12.85%, while the 5-day performance has seen it change 3.16%. Over the past 30 days, the shares of Humana Inc. (NYSE:HUM) have changed 12.16%. Short interest in the company has seen 1.79 Million shares shorted with days to cover at 1.61.
Wall Street analysts have a consensus price target for the stock at $488.24, which means that the shares’ value could jump 5.45% from current levels. The projected low price target is $431 while the price target rests at a high of $557. In that case, then, we find that the current price level is +20.3% off the targeted high while a plunge would see the stock lose -6.91% from current levels.
Humana Inc. (HUM) estimates and forecasts
Figures show that Humana Inc. shares have outperformed across the wider relevant industry. The company’s shares have gained +15.96% over the past 6 months, with this year growth rate of 15.47%, compared to 13.8% for the industry. Other than that, the company has, however, lowered its growth outlook for the 2021 fiscal year revenue. Growth estimates for the current quarter are -46.3% and 62.7% for the next quarter. Revenue growth from the last financial year stood is estimated to be +7.5%.
9 analysts offering their estimates for the company have set an average revenue estimate of $20.45 Billion for the current quarter. 9 have an estimated revenue figure of $20.14 Billion for the next quarter concluding in September 01, 2021. Year-ago sales stood $19.08 Billion and $18.82 Billion respectively for this quarter and the next, and analysts expect sales will grow by 7.2% for the current quarter and 7% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +24.6% over the past 5 years. Earnings growth for 2021 is a modest +26% while over the next 5 years, the company’s earnings are expected to increase by 13.17%.
Humana Inc. is expected to release its next earnings report between July 28 and July 28 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue. The forward dividend is 2.8 at a share yield of 0.62%. The company’s dividend yield has gone up over the past 12 months, with a 5 Year Average Dividend Yield of 0.63%.
Humana Inc. (NYSE:HUM)’s Major holders
Insiders own 0.25% of the company shares, while shares held by institutions stand at 96.91% with a share float percentage of 97.15%. Investors are also buoyed by the number of investors in a company, with Humana Inc. having a total of 1259 institutions that hold shares in the company. The top two institutional holders are Blackrock Inc. with over 11.97 Million shares worth more than $4.91 Billion. As of December 30, 2020, Blackrock Inc. held 9.28% of shares outstanding.
The other major institutional holder is Vanguard Group Inc. (The), with the holding of over 10.17 Million shares as of December 30, 2020. The firm’s total holdings are worth over $4.17 Billion and represent 7.88% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Washington Mutual Investors Fund and Vanguard Total Stock Market Index Fund. As of March 30, 2021, the former fund manager holds about 3.56% shares in the company for having 4591131 shares of worth $1.92 Billion while later fund manager owns 3.73 Million shares of worth $1.53 Billion as of December 30, 2020, which makes it owner of about 2.89% of company’s outstanding stock.